Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 12, 2023
[Japanese patient preferences between ravulizumab and eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria]Ken Ishiyama, Kensuke Usuki, Takayuki Ikezoe, et al.
Blood Cells, Molecules & Diseases|December 20, 2002
The hematopoietic defect in PNH is not due to defective stroma, but is due to defective progenitor cellsJun-ichi Nishimura, Russell E Ware, Angela Burnette, et al.
International Journal of Hematology|July 7, 2019
Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuriaMasatoshi Sakurai, Jun Ho Jang, Wen-Chien Chou, et al.
European Journal of Haematology|May 3, 2022
Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studiesAustin G Kulasekararaj, Morag Griffin, Saskia Langemeijer, et al.
Blood|July 20, 2002
Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitroShoichi Nagakura, Sonoko Ishihara, Daniel E Dunn, et al.
Blood Advances|April 24, 2025
Characterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatmentAustin G Kulasekararaj, Jong Wook Lee, Christopher J Patriquin, et al.
International Journal of Hematology|August 13, 2013
Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trialYuzuru Kanakura, Kazuma Ohyashiki, Tsutomu Shichishima, et al.
International Journal of Hematology|February 10, 2016
Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated reviewNaoyuki Miyasaka, Osamu Miura, Tatsuya Kawaguchi, et al.
Blood|April 4, 2002
Long-term support of hematopoiesis by a single stem cell clone in patients with paroxysmal nocturnal hemoglobinuriaJun-ichi Nishimura Ji, Toshiyuki Hirota, Yuzuru Kanakura, et al.
Internal Medicine (Tokyo, Japan)|August 26, 2021
Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case ReportsYu Ito, Nobuyasu Awano, Fumiya Uchiyama, et al.
Pageof 8